Please login to the form below

Not currently logged in
Email:
Password:

Diane 35

This page shows the latest Diane 35 news and features for those working in and with pharma, biotech and healthcare.

EMA and FDA create pharmacovigilance 'cluster'

EMA and FDA create pharmacovigilance 'cluster'

In the 18 months since it launched, the PRAC has made safety recommendations on Ariad's cancer drug Iclusig (ponatinib) and Bayer's contraceptive Diane 35 (cyproterone acetate) among others.

Latest news

  • France investigates Teva after packaging mix-up France investigates Teva after packaging mix-up

    The furosemide recall is the second major patient safety event that the ANSM has investigated this year, following the recall of Bayer's contraceptive pill Diane 35 and its generics after

  • France ignores EMA and suspends Bayer's Diane 35 France ignores EMA and suspends Bayer's Diane 35

    France ignores EMA and suspends Bayer's Diane 35. National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict. ... Regulators in France have decided to suspend sales of Bayer's acne treatment Diane 35 despite a recommendation

  • EMA says Bayer's Diane 35 should remain on European market EMA says Bayer's Diane 35 should remain on European market

    EMA says Bayer's Diane 35 should remain on European market. Agency investigation concludes acne treatment's benefits outweigh its risks. ... Bayer's controversial acne treatment Diane 35 is to remain on the market in the EU after an investigation

  • Bayer’s Diane 35 faces ban in France Bayer’s Diane 35 faces ban in France

    Bayer’ s Diane 35 faces ban in France. Follows investigation into blood clot-related deaths. ... Regulators in France have suspended the sale of Bayer's acne drug Diane 35 and its generics citing an increased risk of blood clots.

  • EMA starts contraceptive safety probe EMA starts contraceptive safety probe

    EMA starts contraceptive safety probe. Follows French investigation into Bayer’ s Diane 35. ... company's older Diane 35 (ethinylestradiol and cyproterone) product, a combined oral contraceptive which is also used to treat acne.

More from news
Approximately 5 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics